Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Adynovate
Active Ingredient: Rurioctocog alfa pegol 750IU
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Takeda New Zealand Limited
Manufacturer: Baxalta Manufacturing SARL, Neuchatel, Switzerland
   
Product: Adynovate
Active Ingredient: Rurioctocog alfa pegol 1500IU
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Takeda New Zealand Limited
Manufacturer: Baxalta Manufacturing SARL, Neuchatel, Switzerland
   
Product: Adynovate
Active Ingredient: Rurioctocog alfa pegol 3000IU
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Takeda New Zealand Limited
Manufacturer: Baxalta Manufacturing SARL, Neuchatel, Switzerland
   
Product: PIQRAY
Active Ingredient: Alpelisib 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
   
Product:
Component 1:
PIQRAY
Active Ingredient: Alpelisib 50mg
Dosage Form:
Component 2:
Film coated tablet
Active Ingredient: Alpelisib 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
   
Product: PIQRAY
Active Ingredient: Alpelisib 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
   
Product: Slenyto
Active Ingredient: Melatonin 1mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: SwissCo Services AG, Sisseln, Switzerland
Dragenopharm, Apotheker Puschl GmbH & Co. KG, Tittmoning, Germany
Iberfar - Industria Farmaceutica S.A., Barcarena, Portugal
   
Product: Slenyto
Active Ingredient: Melatonin 5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: SwissCo Services AG, Sisseln, Switzerland
Dragenopharm, Apotheker Puschl GmbH & Co. KG, Tittmoning, Germany
Iberfar - Industria Farmaceutica S.A., Barcarena, Portugal


Dated this 29th day of July 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).